Status:
COMPLETED
Residual Vein Thrombosis Establishes the Optimal Duration of Oral Anticoagulants
Lead Sponsor:
Azienda Ospedaliera Universitaria Policlinico
Conditions:
Deep Vein Thrombosis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
ABSTRACT Background The optimal duration of oral anticoagulant treatment in patients with idiopathic venous thromboembolism is still uncertain . The present study addressed the possible role of the Re...
Detailed Description
INTRODUCTION Long-term anticoagulant treatment with adjusted doses of vitamin K antagonists is highly effective in preventing recurrent events after a first episode of unprovoked Venous ThromboEmbolis...
Eligibility Criteria
Inclusion
- First episode of unprovoked and provoked proximal DVT of the lower limbs and treated for 3 month with oral anticoagulants
Exclusion
- Active cancer,
- Limited life expectancy,
- Antiphospholipid antibody syndrome, or an other known thrombophilic status (such as antithrombin deficiency),
- Serious liver disease,
- Renal insufficiency (serum creatinine \> 2 mg/dL).
Key Trial Info
Start Date :
November 1 2003
Trial Type :
INTERVENTIONAL
End Date :
September 1 2006
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT00438230
Start Date
November 1 2003
End Date
September 1 2006
Last Update
February 22 2007
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.